Position in AMGN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,125,095
+$8,760 QoQ
Shares Held
8,630
-2.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#1,052
of 3,139 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MV CAPITAL MANAGEMENT, INC. holds $82,370,025 across 15 Drug Manufacturers - General names. AMGN ranks #3 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
271,250 | $68,257,350 | |
| 2 | JNJ |
Johnson & Johnson
|
14,678 | $3,727,771 | |
| 3 | AMGN |
Amgen Inc
This page
|
8,630 | $3,125,095 | |
| 4 | LLY |
ELI LILLY & Co
|
2,477 | $2,970,988 | |
| 5 | MRK |
Merck & Co., Inc.
|
22,792 | $2,928,772 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,582 | $957,909 | |
| 7 | PFE |
Pfizer Inc
|
10,065 | $242,365 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,153 | $66,435 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,125,095 | 8,630 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $3,116,335 | 8,857 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,907,167 | 8,882 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $2,470,096 | 8,753 | Shares | Sole | 2026-02-23 | |
| 2025-06-30 | $2,210,784 | 7,918 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,508,912 | 8,053 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $2,240,200 | 8,595 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,761,661 | 8,571 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,514,597 | 8,048 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,264,608 | 7,965 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $2,242,235 | 7,785 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $2,111,647 | 7,857 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,716,880 | 7,733 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,743,259 | 7,211 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $1,751,808 | 6,670 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,493,500 | 6,626 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $1,765,871 | 7,258 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $1,756,338 | 7,263 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,571,190 | 6,984 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,430,071 | 6,725 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,571,700 | 6,448 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,419,958 | 5,707 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,513,793 | 6,584 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,494,714 | 5,881 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,221,518 | 5,179 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $934,179 | 4,608 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||